Home » Nelli Morgulchik

Nelli Morgulchik

Analyst

Nelli Morgulchik is an Analyst at CBPartners.

Connect with Nelli Morgulchik

nelli.morgulchik@cbpartners.com

LinkedIn

Published Articles

Opportunities and Barriers for Biosimilar Uptake in the USA

In the first of a multi-part biosimilar podcast series, CBPartners Healthcare Consultants are joined by special guest Dr. Bhavesh Shah, Senior Director of Pharmacy Strategy at Boston Medical Center, to explore the evolving biosimilar landscape in the USA.

USA Policy Expectations for a New Administration

This episode, which kicks off season two of CBPartners’ Pharma Take-away, discusses the possible evolution of healthcare and healthcare policy in the United States, and explores the changes we may expect over the next few years as a result of the presidential election party transition.

The UK Introduces New Access and Licensing Pathway for Innovative Medicines

Digital Health (pt 3): Emergence of Companion Digital Treatments and Standalone Digital Therapeutics